Shekhat Denil Nanji

Shekhat Denil Nanji is listed in filings as Director at MIRA Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Oct 3, 2025, including 3 public disclosures. Recent filings connect the profile to MIRA Pharmaceuticals, Inc. (MIRA). The current snapshot covers public activity from Jun 21, 2024 to Oct 3, 2025. Reported amounts are shown as $30.2K to $35.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.